ATE377417T1 - Verwendung von stickstoffoxyddonoren oder - antagonisten zur regulierung der dehnung der zervix - Google Patents

Verwendung von stickstoffoxyddonoren oder - antagonisten zur regulierung der dehnung der zervix

Info

Publication number
ATE377417T1
ATE377417T1 AT96909707T AT96909707T ATE377417T1 AT E377417 T1 ATE377417 T1 AT E377417T1 AT 96909707 T AT96909707 T AT 96909707T AT 96909707 T AT96909707 T AT 96909707T AT E377417 T1 ATE377417 T1 AT E377417T1
Authority
AT
Austria
Prior art keywords
donors
nitric oxide
oxyd
distention
cervix
Prior art date
Application number
AT96909707T
Other languages
English (en)
Inventor
Kristof Chwalisz
Robert E Garfield
Original Assignee
Univ Texas
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Texas filed Critical Univ Texas
Application granted granted Critical
Publication of ATE377417T1 publication Critical patent/ATE377417T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/04—Nitro compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/223—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of alpha-aminoacids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A61K31/295—Iron group metal compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/04—Drugs for genital or sexual disorders; Contraceptives for inducing labour or abortion; Uterotonics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/06—Antiabortive agents; Labour repressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Emergency Medicine (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Gynecology & Obstetrics (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Materials For Medical Uses (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
AT96909707T 1995-03-14 1996-03-14 Verwendung von stickstoffoxyddonoren oder - antagonisten zur regulierung der dehnung der zervix ATE377417T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP95250059 1995-03-14

Publications (1)

Publication Number Publication Date
ATE377417T1 true ATE377417T1 (de) 2007-11-15

Family

ID=8221039

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96909707T ATE377417T1 (de) 1995-03-14 1996-03-14 Verwendung von stickstoffoxyddonoren oder - antagonisten zur regulierung der dehnung der zervix

Country Status (26)

Country Link
US (1) US6333350B1 (de)
EP (1) EP0814785B1 (de)
JP (1) JP4579349B2 (de)
KR (2) KR100434239B1 (de)
CN (1) CN1151781C (de)
AT (1) ATE377417T1 (de)
AU (1) AU713172B2 (de)
CA (1) CA2214779A1 (de)
CZ (1) CZ292395B6 (de)
DE (1) DE69637313T2 (de)
ES (1) ES2297838T3 (de)
HU (1) HUP9800826A3 (de)
ID (1) ID20742A (de)
IL (1) IL117496A (de)
IS (1) IS4555A (de)
MX (1) MX9707007A (de)
MY (1) MY116500A (de)
NO (1) NO318598B1 (de)
NZ (1) NZ305169A (de)
PL (1) PL183461B1 (de)
RU (1) RU2199346C2 (de)
SK (1) SK124197A3 (de)
TW (1) TW421594B (de)
UA (1) UA57703C2 (de)
WO (1) WO1996028145A1 (de)
ZA (1) ZA962089B (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4579349B2 (ja) 1995-03-14 2010-11-10 バイエル・シエーリング・ファーマ アクチエンゲゼルシャフト 子宮頸の拡大及び拡張度を制御するための酸化窒素供与体及び／又は基質又は酸化窒素インヒビター
WO1997031631A1 (en) * 1996-02-27 1997-09-04 Rpms Technology Limited Cox-2 selective inhibitors for managing labour and uterine contractions
US6232434B1 (en) 1996-08-02 2001-05-15 Duke University Medical Center Polymers for delivering nitric oxide in vivo
DE19809845A1 (de) 1998-03-03 1999-09-09 Jenapharm Gmbh S-substituierte 11beta-Benzaldoxim-estra-4,9-dien-kohlensäurethiolester, Verfahren zu deren Herstellung und diese Verbindungen enthaltende pharmazeutische Zubereitungen
ITMI20002117A1 (it) * 2000-09-29 2002-03-29 Ibsa Inst Biochimique Sa Uso di sodio nitroprussiato in ostetricia e ginecologia
WO2005023189A2 (en) * 2003-09-03 2005-03-17 Pharmacia Corporation Method of cox-2 selective inhibitor and nitric oxide-donating agent
WO2006089561A1 (en) * 2005-02-23 2006-08-31 Abbas Abdelsalam Ghazi Pharmaceutical compositions containing organic acids useful for softening and ripening uterine cervix.
US8828981B2 (en) 2007-02-06 2014-09-09 George Creasy Progesterone for the treatment or prevention of spontaneous preterm birth
CN102283827A (zh) * 2008-10-16 2011-12-21 四川维信医药科技有限责任公司 单硝酸异山梨酯的新用途

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5508045A (en) 1992-10-09 1996-04-16 The Regents Of The University Of California Method and agents for control and management of labor during pregnancy
HUT74465A (en) * 1993-11-16 1996-12-30 Schering Ag Pharmaceutical composition which useable for treatment of uterine contractility disorders containing a nitric oxide synthase substrate and/or donor, or a nitric oxide inhibitor
US5550369A (en) 1994-02-28 1996-08-27 Electro-Pro, Inc. Triangulation position detection method and apparatus
JP4579349B2 (ja) 1995-03-14 2010-11-10 バイエル・シエーリング・ファーマ アクチエンゲゼルシャフト 子宮頸の拡大及び拡張度を制御するための酸化窒素供与体及び／又は基質又は酸化窒素インヒビター

Also Published As

Publication number Publication date
PL322252A1 (en) 1998-01-19
KR100434239B1 (ko) 2004-06-09
IL117496A0 (en) 1997-03-18
TW421594B (en) 2001-02-11
SK124197A3 (en) 1998-06-03
EP0814785A1 (de) 1998-01-07
IS4555A (is) 1997-09-05
NO974204L (no) 1997-11-13
MX9707007A (es) 1998-06-30
ID20742A (id) 1999-02-25
PL183461B1 (pl) 2002-06-28
IL117496A (en) 2002-12-01
CN1151781C (zh) 2004-06-02
CZ285197A3 (cs) 1998-03-18
ZA962089B (en) 1997-08-27
ES2297838T3 (es) 2008-05-01
RU2199346C2 (ru) 2003-02-27
CZ292395B6 (cs) 2003-09-17
JPH11502200A (ja) 1999-02-23
MY116500A (en) 2004-02-28
DE69637313D1 (de) 2007-12-20
AU713172B2 (en) 1999-11-25
UA57703C2 (uk) 2003-07-15
WO1996028145A1 (en) 1996-09-19
JP4579349B2 (ja) 2010-11-10
HUP9800826A3 (en) 1998-08-28
KR19980703060A (ko) 1998-09-05
NZ305169A (en) 1999-10-28
NO318598B1 (no) 2005-04-18
DE69637313T2 (de) 2008-09-04
AU5311796A (en) 1996-10-02
KR20040004515A (ko) 2004-01-13
KR100434238B1 (ko) 2004-07-16
EP0814785B1 (de) 2007-11-07
HUP9800826A1 (hu) 1998-07-28
US6333350B1 (en) 2001-12-25
NO974204D0 (no) 1997-09-12
CA2214779A1 (en) 1996-09-19
CN1182366A (zh) 1998-05-20

Similar Documents

Publication Publication Date Title
ATE377417T1 (de) Verwendung von stickstoffoxyddonoren oder - antagonisten zur regulierung der dehnung der zervix
DE69830513D1 (de) HEMMUNG DER p38 KINASE UNTER VERWENDUNG VON SYMMETRISCHEN UND ASYMMETRISCHEN DIPHENYLHARNSTOFFEN
DE69317578T2 (de) Verwendung von riluzole zur behandlung von traumatischen neurologischen-schädigungen
DE69221501T2 (de) Verfahren zum vermindern von durch medizinische vorrichtungen bedingten infektionen
DE3650403T3 (de) Polyphosphonat enthaltende Packung zur Behandlung von Osteoporose.
ZA963281B (en) Alpha-substituted pyrimidine-thioalkyl and alkylether compounds.
DE59410358D1 (de) Verwendung von carnosin in kombination mit urocaninsäure zur behandlung von photodermatosen
DE69634269D1 (de) Verfahren zum modulieren der mikrozirkulation
DE69332567T2 (de) Inhibitoren von metazoan-parasit-proteasen
NO960775L (no) Anvendelse av kinoksaliner i kombinasjon med proteaseinhibitorer som legemiddel for behandling av AIDS og/eller HIV-infeksjoner
DK0954305T3 (da) Anvendelse af carbonanhydraseinhibitorer til behandling af maculaødem
NO984950L (no) Forbindelser med veksthormonfrigj°rende egenskaper
ITMI922263A1 (it) Ammine eterocicliche utili nella terapia dell'asma e dell'infiammazione delle vie aeree
ATE212833T1 (de) Verwendung von stickstoffoxid-synthase-substrat und/oder -donor oder stickstoffoxidhemmer zur herstellung von medikamenten zur behandlung von störungen der uterinen kontraktilität
FI925144A (fi) Anvaendning av inhibitorer foer faergutvecklingen i kromogena bestaemningar
GR3036241T3 (en) METHOD OF TREATMENT OF CHRONIC PROSTATITIS WITH 17-g(b)-N-MONOSUBSTITUTED-CARBAMOYL-4-AZA-5-g(a)-ANDROST-1-EN-3-ONES.
DE69412178D1 (de) Apparat zur Behandlung von Lagen
FI952018A0 (fi) BHAP-yhdisteiden käyttö yhdessä muiden ei-nukleosidi-käänteistransskriptaasi-inhibiittoreiden kanssa HIV-infektion hoitoon
DE3878529D1 (de) Vorrichtung zur behandlung von verstauchungen, insbesondere der sprunggelenke sowie zur vermeidung von dabei auftretenden bestimmten komplikationen.
DE59410340D1 (de) Verwendung von Bradykinin-Antagonisten zur Behandlung von Viruserkrankungen
ATE85750T1 (de) Vorrichtung zur behandlung von verstauchungen, insbesondere der sprunggelenke sowie zur vermeidung von dabei auftretenden bestimmten komplikationen.
UA29236A (uk) Спосіб лікування пізніх гестозів

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties